Shanaz sharaf | Immunology and histopathology | Best Researcher Award

Mrs. Shanaz sharaf | Immunology and histopathology | Best Researcher Award

PhD Scholar of Regional Cancer Centre, India

Mrs. Shanaz Sharaf is a dedicated researcher with 7 years of experience in biotechnology, biomedical sciences, cell and molecular biology, and clinical research. ๐ŸŽ“ Her work primarily focuses on understanding prognostic tumor markers in Triple Negative Breast Cancer (TNBC), exploring molecular and cell signaling aspects in tumorigenesis, and developing innovative technologies for cancer detection. ๐Ÿงฌ Passionate about advancing cancer research, Mrs. Sharaf is committed to creating novel multiplex technologies for tumor tissue imaging. She aims to leverage her skills and knowledge in a collaborative environment to contribute to cutting-edge scientific advancements and gain exposure to emerging technologies. ๐ŸŒŸ

Professional profile

Education๐Ÿ“š

Mrs. Shanaz Sharaf holds a Doctor of Philosophy (Ph.D.) in Biotechnology from Manipal Academy of Higher Education, India, where she conducted research on prognostic markers and multiplex platforms for breast cancer classification. ๐Ÿ“š Her academic journey includes a Master of Science in Biotechnology from the University of Kerala, graduating with first-class honors and a distinction of 75.05%. ๐ŸŽ“ Prior to that, she earned a Bachelor of Science in Botany and Biotechnology from the University of Kerala, also with first-class honors and a notable 74.05%. ๐ŸŒŸ Her educational background equips her with a strong foundation in biotechnological and biomedical sciences, essential for her research endeavors.

Professional Experience๐Ÿ›๏ธ

Mrs. Shanaz Sharaf brings a wealth of experience to her field, having served as a PhD Scholar at the Regional Cancer Centre, Thiruvananthapuram, Kerala, India, from 2019 to 2024. ๐ŸŽ“ Her research focused on identifying prognostic markers and developing multiplex platforms for breast cancer classification under the guidance of Dr. K Sujathan. ๐Ÿงฌ Prior to her PhD, she worked as a Junior Research Fellow on translational research in Triple Negative Breast Cancer (2017-2019) and investigated maternal sleep deprivation effects on offspring cognition (2014-2015) at SCTIMST, Thiruvananthapuram. ๐Ÿ”ฌ Her extensive research background showcases her expertise in molecular and cell biology, particularly in cancer research and innovative diagnostic techniques. ๐Ÿงช

Research Interest๐ŸŒ

Mrs. Shanaz Sharaf’s research interests lie in the intersection of biotechnology and cancer research. ๐Ÿ”ฌ Her primary focus is on understanding the role of prognostic tumor markers in Triple Negative Breast Cancer (TNBC), aiming to enhance disease outcome predictions and improve detection methods. ๐Ÿงฌ She explores various molecular and cell signaling pathways involved in tumorigenesis and is passionate about developing novel multiplex technologies for tumor tissue imaging. ๐Ÿงช Her work seeks to innovate cancer detection and treatment, leveraging cutting-edge techniques to advance the field of oncology. ๐ŸŒŸ

Awards and Honors๐Ÿ†

Mrs. Shanaz Sharaf has received notable recognition for her contributions to cancer research and biotechnology. ๐Ÿ… Her commitment to advancing the field has been acknowledged through various awards and honors. ๐ŸŽ–๏ธ These accolades highlight her innovative work and dedication, reflecting her impact on the scientific community and her role in pioneering new approaches to cancer detection and treatment. ๐ŸŒŸ Her achievements underscore her excellence and commitment to improving health outcomes through research and innovation. ๐ŸŒบ

Achievements๐Ÿ…
  • ๐ŸŽ“ Doctoral Research: Completed a Ph.D. in Biotechnology at Manipal Academy of Higher Education, focusing on identifying prognostic markers and developing multiplex platforms for breast cancer classification.
  • ๐Ÿงฌ Research Contributions: Significant work in Triple Negative Breast Cancer, including translational research and novel strategies in cancer detection.
  • ๐Ÿ”ฌ Conference Organization: Actively involved in organizing major conferences like the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research (2019) and the National Conference on ETHB (2023).
  • ๐Ÿ“š Research Experience: Junior Research Fellow (JRF) with projects on maternal sleep deprivation effects and translational research in breast cancer.
  • ๐Ÿ† Professional Recognition: Contributed to significant research advancements and gained recognition within the scientific community for her innovative approaches and findings.
  • ๐Ÿ’ก Innovative Technologies: Development of innovative multiplex technologies for tumor tissue imaging, enhancing cancer research methodologies.
Projects๐Ÿ› ๏ธ
  • ๐Ÿ” Prognostic Markers in Breast Cancer: Identified a panel of prognostic markers and developed a multiplex platform for histoclinical classification of breast cancer during her Ph.D. research at the Regional Cancer Centre.
  • ๐Ÿงฌ Triple Negative Breast Cancer: Conducted translational research focusing on the role of various prognostic tumor markers in Triple Negative Breast Cancer.
  • ๐Ÿงช Maternal Sleep Deprivation Study: Investigated the effects of maternal sleep deprivation on cognition in offspring using an animal model during her tenure as a Junior Research Fellow.
  • ๐Ÿงฉ Tumor Tissue Imaging: Worked on developing innovative multiplex technologies for enhanced imaging of tumor tissues.
  • ๐Ÿ—‚๏ธ Conference Organization: Played a key role in organizing major conferences, including the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research and the National Conference on ETHB.
Publications top noted๐Ÿ“œ
  • ๐Ÿ“„ “Subcellular expression of MTA1, HIF1A, and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study”
    • Authors: Sharaf, S.S., Jaganath Krishna, K.M., Lekshmi, A., Sujathan
    • Journal: Journal of Molecular Histology
    • Year: 2024
    • Volume: 55
    • Issue: 3
    • Pages: 303โ€“315
    • Citations: 0
  • ๐Ÿ“„ “A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor – Quantum dot conjugates and a panel of chromogenic dyes”
    • Authors: Sharaf, S.S., Lekshmi, A., S, A., Santhosh Kumar, T.R., K, S.
    • Journal: Pathology Research and Practice
    • Year: 2024
    • Volume: 253
    • Article: 155033
    • Citations: 1